NATERA INC (NTRA) Stock News
NASDAQ:NTRA - Nasdaq - US6323071042 - Common Stock - Currency: USD
NTRA Latest News, Press Relases and Analysis
NATERA INC is setting up nicely for a breakout.
Exploring NATERA INC's Technical Signals and Breakout Potential: A technical analysis of NATERA INC (NASDAQ:NTRA) shows it may be setting up for a breakout.
Why NATERA INC (NASDAQ:NTRA) qualifies as a high growth stock.
Should you consider NATERA INC (NASDAQ:NTRA) for high growth investing? A fundamental and technical analysis of (NASDAQ:NTRA).
Natera to Report its Fourth Quarter and Full Year Results on February 27, 2025
Billionaire Investor Stanley Druckenmiller Dumps Broadcom, Bets Big On Tesla, Amazon And Other Big Tech Stocks In Q4
Billionaire investor Stanley Druckenmiller's family office Duquesne has divested his entire stake in Broadcom, simultaneously increasing his investments in major tech companies, as revealed in a recent 13-F filing.
NCCN Strengthens Guidance on ctDNA in Colon Cancer, Rectal Cancer, and Merkel Cell Carcinoma
Natera Announces National Commercial Coverage for its Fetal RhD NIPT
Natera to Present New Data at the 2025 ASCO GI Symposium
Why Top 4% Guardant Health Surged To A 13-Month High And Topped A Profit-Taking Zone
The company is working to expand the uses and reimbursement for its blood-based tests for cancer.
Natera Announces Innovation Roadmap, with Advancements in MRD and Early Cancer Detection
Natera Announces Preliminary Fourth Quarter and Full-Year Results for 2024
Here Are Billionaire Stanley Druckenmiller's 5 Biggest Stock Holdings
Natera to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
Stocks Mostly Down Pre-Bell Ahead of Holiday-Shortened Trading Week; Asia, Europe Up
The benchmark US stock measures were mostly trending lower before the opening bell Monday, as trader
Here Are Billionaire Stanley Druckenmiller's 5 Biggest Stock Holdings
Court Grants Natera’s Request to Include Additional Patent in its Lawsuit Against NeoGenomics
Natera and MyOme Announce Launch of iPRS™ for Breast Cancer Risk Assessment
Clinical Validation Study on Natera’s Fetal RhD NIPT Published in Obstetrics & Gynecology
Natera Announces Medicare Coverage for Prospera™ in Single Lung Transplant Recipients
